Basic Information
| LncRNA/CircRNA Name | LINC01561 |
| Synonyms | NA |
| Region | GRCh38_10:120597949-120600124 |
| Ensemble | ENSG00000177234 |
| Refseq | NR_103717 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blot |
| Sample | NSCLC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | SOX2-induced overexpression of LINC01561 promoted the proliferation and metastasis by acting as a competing endogenous RNA to modulate SHCBP1 by sponging miR-760. |
| Pubmed ID | 32003010 |
| Year | 2020 |
| Title | SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression |
External Links
| Links for LINC01561 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |